| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.88▼ | 4.88▼ | 4.86▼ | 4.58▲ | 4.02▲ |
| MA10 | 4.89▼ | 4.84▲ | 4.83▲ | 4.29▲ | 3.93▲ |
| MA20 | 4.88▼ | 4.83▲ | 4.73▲ | 4.01▲ | 6.36▼ |
| MA50 | 4.85▲ | 4.62▲ | 4.37▲ | 4.41▲ | 8.10▼ |
| MA100 | 4.83▲ | 4.30▲ | 4.02▲ | 6.72▼ | 7.16▼ |
| MA200 | 4.76▲ | 3.99▲ | 4.06▲ | 8.07▼ | 8.10▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.004▼ | -0.009▼ | -0.011▼ | 0.180▲ | -0.146▼ |
| RSI | 41.719▼ | 58.128▲ | 65.270▲ | 65.118▲ | 39.873▼ |
| STOCH | 56.005 | 80.915▲ | 62.644 | 89.492▲ | 30.555 |
| WILL %R | -100.000▼ | -34.483 | -34.483 | -7.509▲ | -70.030 |
| CCI | -148.936▼ | 64.804 | 104.824▲ | 144.672▲ | -22.931 |
|
Thursday, January 15, 2026 01:33 AM
Anavex Life Sciences (NASDAQ:AVXL) outlined its strategy to develop oral, precision-medicine therapies for central nervous system (CNS) diseases during a presentation at the J.P. Morgan Healthcare ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 15/01/26 | 4.6694 | 4.96 | 4.6694 | 4.85 | 1,138,283 |
| 14/01/26 | 4.68 | 4.91 | 4.67 | 4.82 | 2,134,800 |
| 13/01/26 | 4.37 | 4.70 | 4.21 | 4.64 | 1,872,800 |
| 12/01/26 | 4.30 | 4.34 | 4.11 | 4.29 | 987,600 |
| 09/01/26 | 4.37 | 4.435 | 4.20 | 4.28 | 1,483,900 |
| 08/01/26 | 4.09 | 4.31 | 3.97 | 4.27 | 1,270,500 |
| 07/01/26 | 3.99 | 4.195 | 3.97 | 4.10 | 1,600,200 |
| 06/01/26 | 4.125 | 4.37 | 3.985 | 4.01 | 2,704,700 |
| 05/01/26 | 3.66 | 3.976 | 3.645 | 3.95 | 1,559,400 |
| 02/01/26 | 3.63 | 3.71 | 3.495 | 3.68 | 1,544,113 |
|
|
||||
|
|
||||
|
|